Literature DB >> 4344395

Nasal secretion protein responses in patients with wild-type adenovirus disease.

D P McCormick, R P Wenzel, J A Davies, W E Beam.   

Abstract

Proteins were studied in nasal secretions obtained from Marine Corps trainees infected with wild adenovirus type 7 both during the acute phase of illness and after recovery. Illness was associated with a marked increase in the concentration of serum proteins in the secretions, and during inflammation there was no apparent barrier to the passage of large molecules (molecular weight 775,000) from the serum into the respiratory passages. At the time of virus isolation, trainees requiring hospitalization had less immunoglobulin A (IgA) in their secretions even though they had greater quantities of immunoglobin G (P < 0.05) and albumin than trainees followed in the field, whose secretions were also tested at the time of virus isolation. Base-line IgA and protein concentrations were lower (P < 0.05) in hospitalized trainees than in trainees followed prospectively in the field. The results suggest a nonspecific protective function for secretion protein, although we have not excluded the possibility that field study trainees were protected by specific neutralizing antibody present in the nasal secretion.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4344395      PMCID: PMC422529          DOI: 10.1128/iai.6.3.282-288.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Comparison of protective effect of neutralizing antibody in serum and nasal secretions in experimental rhinovirus type 13 illness.

Authors:  J C Perkins; D N Tucker; H L Knopf; R P Wenzel; A Z Kapikian; R M Chanock
Journal:  Am J Epidemiol       Date:  1969-12       Impact factor: 4.897

2.  The proteins in nasal secretion: a longitudinal study of the gammaA-globulin, gammaG-globulin, albumin, siderophilin, and total protein concentrations in nasal washings from adult male volunteers.

Authors:  R D Rossen; A L Schade; W T Butler; J A Kasel
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

3.  Localization of immunoglobulins in human nasal mucosa.

Authors:  P Brandtzaeg; I Fjellanger; S T Gjeruldsen
Journal:  Immunochemistry       Date:  1967-01

4.  Interferon and resistance to upper respiratory virus illness.

Authors:  T R Cate; R G Douglas; R B Couch
Journal:  Proc Soc Exp Biol Med       Date:  1969-06

5.  Poliovirus antibody response in serum and nasal secretions following intranasal inoculation with inactivated poliovaccine.

Authors:  P L Ogra; D T Karzon
Journal:  J Immunol       Date:  1969-01       Impact factor: 5.422

6.  Immunoglobulin responses in serum and nasal secretions after natural adenovirus infections.

Authors:  J A Bellanti; M S Artenstein; B L Brandt; B S Klutinis; E L Buescher
Journal:  J Immunol       Date:  1969-11       Impact factor: 5.422

7.  Human influenza: aspects of the immune response to vaccination.

Authors: 
Journal:  Ann Intern Med       Date:  1969-08       Impact factor: 25.391

8.  Protein composition of nasal secretion during respiratory virus infection.

Authors:  R D Rossen; W T Butler; T R Cate; C F Szwed; R B Couch
Journal:  Proc Soc Exp Biol Med       Date:  1965 Aug-Sep

9.  Antibody responses in serum and nasal secretions according to age of recipient and method of administration of A2-Hong Kong-68 inactivated influenza virus vaccine.

Authors:  R V Fulk; D S Fedson; M A Huber; J R Fitzpatrick; J A Kasel
Journal:  J Immunol       Date:  1970-01       Impact factor: 5.422

10.  The human secretory immunoglobulin system: immunohistoligical localization of gamma A, secretory "piece," and lactoferrin in normal human tissues.

Authors:  D R Tourville; R H Adler; J Bienenstock; T B Tomasi
Journal:  J Exp Med       Date:  1969-02-01       Impact factor: 14.307

View more
  2 in total

1.  Effect of specific humoral immunity and some non-specific factors on resistance of volunteers to respiratory coronavirus infection.

Authors:  K A Callow
Journal:  J Hyg (Lond)       Date:  1985-08

2.  Microfluidic chip for fast bioassays-evaluation of binding parameters.

Authors:  Jakub Stepánek; Michal Pribyl; Dalimil Snita; Milos Marek
Journal:  Biomicrofluidics       Date:  2007-04-25       Impact factor: 2.800

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.